MarketCap
Facebook
X
TelegramQuartalsbericht 2023-Q3
hinzugefügt 09.11.2023
NeuBase Therapeutics ROE 2011-2026 | NBSE
ROE Jährlich NeuBase Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -145.64 | -46.99 | -55.55 | -268.79 | -121.43 | -104.23 | -103.22 | -35.77 | -34.13 | -107.38 | -59.96 | 106.69 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 106.69 | -268.79 | -81.37 |
ROE Vierteljährlich NeuBase Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -102.88 | -115.86 | -113.23 | -110.9 | -103.32 | -104.17 | -90.53 | -87.59 | -85.45 | -92.23 | -91.18 | -82.37 | -132.22 | -147.06 | -162.68 | -212.53 | 230.81 | 277.27 | 297.31 | 352.51 | -47.81 | -120.18 | -128.35 | -140.53 | -146.43 | -91.74 | -105.51 | -112.37 | -101.18 | -83.8 | -60.83 | -47.35 | -51.63 | -53.97 | -53.77 | -56.49 | -83.0 | -105.72 | -123.47 | -144.69 | -508.73 | -537.21 | -530.78 | -583.8 | -183.33 | -42.3 | 42.3 | 126.4 | 78.28 | 65.62 | -7.33 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 352.51 | -583.8 | -90.51 |
ROE anderer Aktien in der Pharmaeinzelhändler
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
ADC Therapeutics SA
ADCT
|
-138.5 | $ 3.78 | - | $ 105 M |  Schweiz |
 |
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M |  Germany |
 |
Akebia Therapeutics
AKBA
|
-16.39 | $ 1.35 | -2.17 % | $ 347 M |  USA |
 |
Akari Therapeutics, Plc
AKTX
|
-61.06 | $ 3.5 | -21.7 % | $ 236 B |  Britain |
 |
Aldeyra Therapeutics
ALDX
|
-76.49 | $ 1.58 | -4.82 % | $ 94.9 M | USA |
 |
Aligos Therapeutics
ALGS
|
-45.18 | $ 8.36 | 4.89 % | $ 82.6 M | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
39.76 | $ 330.71 | 3.72 % | $ 43.3 B | USA |
 |
Altimmune
ALT
|
-39.17 | $ 3.47 | 3.89 % | $ 306 M | USA |
 |
ALX Oncology Holdings
ALXO
|
-391.42 | $ 1.98 | 0.25 % | $ 106 M | USA |
 |
Amgen
AMGN
|
89.06 | $ 346.45 | -0.43 % | $ 186 B | USA |
 |
I-Mab
IMAB
|
-85.31 | - | - | $ 866 M |  China |
 |
Amneal Pharmaceuticals
AMRX
|
-101.78 | $ 12.37 | -0.92 % | $ 3.88 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
626.29 | - | 2.54 % | $ 160 B |  France |
 |
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M | France |
 |
Anika Therapeutics
ANIK
|
-38.95 | $ 15.0 | 1.32 % | $ 220 M | USA |
 |
ANI Pharmaceuticals
ANIP
|
-4.59 | $ 76.34 | 2.87 % | $ 1.47 B | USA |
 |
Annexon
ANNX
|
-97.66 | $ 5.64 | 2.45 % | $ 875 M | USA |
 |
Aptorum Group Limited
APM
|
-20.19 | $ 0.92 | -1.11 % | $ 5.02 M | China |
 |
Midatech Pharma plc
MTP
|
-330.29 | - | -18.52 % | $ 27.3 M | Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | USA |
 |
Aprea Therapeutics
APRE
|
-101.27 | $ 0.73 | 2.63 % | $ 4.77 M | USA |
 |
Aquestive Therapeutics
AQST
|
248.9 | $ 4.15 | 0.48 % | $ 444 M | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
-30.74 | $ 8.43 | 4.98 % | $ 231 M |  Israel |
 |
Ardelyx
ARDX
|
-36.9 | $ 6.08 | 2.27 % | $ 1.47 B | USA |
 |
Acorda Therapeutics
ACOR
|
160.08 | - | -24.86 % | $ 820 K | USA |
 |
Arcutis Biotherapeutics
ARQT
|
-8.52 | $ 23.93 | 1.27 % | $ 3.04 B | USA |
 |
Arvinas
ARVN
|
-18.62 | $ 11.11 | 2.4 % | $ 788 M | USA |
 |
Adverum Biotechnologies
ADVM
|
-185.15 | - | - | $ 86.2 M | USA |
 |
Arrowhead Pharmaceuticals
ARWR
|
-0.35 | $ 61.57 | 0.88 % | $ 8.24 B | USA |
 |
Advaxis
ADXS
|
196.88 | - | -9.65 % | $ 45.9 M | USA |
 |
Applied Molecular Transport
AMTI
|
-207.64 | - | - | $ 10.1 M | USA |
 |
Assembly Biosciences
ASMB
|
-2.96 | $ 30.01 | 3.43 % | $ 336 M | USA |
 |
Aeterna Zentaris
AEZS
|
-401.79 | - | 5.93 % | $ 314 M |  Canada |
 |
AgeX Therapeutics
AGE
|
51843.24 | - | -10.17 % | $ 12.2 K | USA |
 |
AIkido Pharma
AIKI
|
-32.34 | - | 1.93 % | $ 17.4 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-21.7 | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
-62.37 | - | - | $ 26.5 M | USA |
 |
Akero Therapeutics
AKRO
|
-33.6 | - | - | $ 3.67 B | USA |
 |
Akouos
AKUS
|
-37.09 | - | 0.23 % | $ 488 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - |  Russia |
 |
Actinium Pharmaceuticals
ATNM
|
-432.56 | $ 1.14 | 16.28 % | $ 35.6 M | USA |
 |
Atossa Therapeutics
ATOS
|
-88.35 | $ 5.21 | -2.89 % | $ 44.9 M | USA |
 |
Atara Biotherapeutics
ATRA
|
-84.9 | $ 5.03 | 0.7 % | $ 63.1 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
-257.91 | - | 3.16 % | $ 1.9 M | USA |
 |
Aurinia Pharmaceuticals
AUPH
|
36.26 | $ 16.04 | 2.75 % | $ 2.16 B | Canada |
 |
Autolus Therapeutics plc
AUTL
|
-161.42 | $ 1.42 | 0.35 % | $ 378 M | Britain |
 |
Alpine Immune Sciences
ALPN
|
-32.19 | - | - | $ 2.17 B | USA |
 |
Aileron Therapeutics
ALRN
|
-294.78 | - | 10.36 % | $ 9.8 M | USA |